Dan Burrows

Dan Burrows

Dan Burrows is a veteran of CBS MoneyWatch, DailyFinance, SmartMoney and Dow Jones MarketWatch, and has written for The Wall Street Journal, Consumer Reports and other publications. He favors value investing and writes about asset prices and macroeconomic trends for the long-term investor. He holds no individual securities.

Recent Articles

5 Stocks to Buy for August

Strong technicals say these 5 companies are the right stocks to buy for outperformance during an otherwise sleepy month for the market.

So Much for Q2! Groupon Blasted After Earnings (GRPN)

Groupon stock plunged in after-hours trading as weak guidance and a top-line miss revealed how tough GRPN's transition into an e-commerce player really is.

Why Apple & Visa Should Join in Mobile Payment Matrimony (AAPL, V)

A strategic alliance between AAPL and V in mobile payments would drive incremental revenue and upside for Visa and Apple stock.

What Is the Export-Import Bank?

The Export-Import Bank, which is under threat of closure, helps everyone from small businesses to Boeing stay competitive in foreign trade.

Are Emerging Markets Back?

Strong contributions from emerging markets in Q2 are helping U.S. companies post the best earnings growth in years.

GoPro Earnings Not Radical Enough to Meet Some Gnarly Expectations

GoPro earnings beat the Street, but not by enough to prevent some selling in previously hot-running GPRO stock.

World Cup Winners & Losers This Earnings Season

Effects from the World Cup are showing up in quarterly reports, but whether for good or ill, the pops and drops are only temporary.

3D Systems Chokes – Dump 3D Printing Companies at Will (DDD, SSYS, XONE)

3D printing companies tumbled yet again after 3D Systems blew Street estimates and sucked the mo-mo out of these momentum stocks.

5 Stocks to Sell for August

These names are flashing technical warning signs, making them appropriate stocks to sell for the sleepy month of August.

Herbalife Stock Tanks on Earnings, Not Ackman

A rare profit was offset by a revenue miss, which smashed Herbalife stock in the midst of a loser of a year.